Literature DB >> 17540912

Drug resistant HIV.

Hiroyu Hatano, Steven G Deeks.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17540912      PMCID： PMC1885311          DOI： 10.1136/bmj.39205.386609.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.

Authors:  D J Hazuda; P Felock; M Witmer; A Wolfe; K Stillmock; J A Grobler; A Espeseth; L Gabryelski; W Schleif; C Blau; M D Miller
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

2.  HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Authors:  Timothy J Wilkin; Zhaohui Su; Daniel R Kuritzkes; Michael Hughes; Charles Flexner; Robert Gross; Eoin Coakley; Wayne Greaves; Catherine Godfrey; Paul R Skolnik; Joseph Timpone; Benigno Rodriguez; Roy M Gulick
Journal:  Clin Infect Dis       Date:  2007-01-17       Impact factor: 9.079

3.  Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.

Authors:  Peter W Hunt; P Richard Harrigan; Wei Huang; Michael Bates; David W Williamson; Joseph M McCune; Richard W Price; Serena S Spudich; Harry Lampiris; Rebecca Hoh; Teri Leigler; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2006-08-29       Impact factor: 5.226

Review 4.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.

Authors:  John P Moore; Scott G Kitchen; Pavel Pugach; Jerome A Zack
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205
  4 in total
  3 in total

Review 1.  Current and future antiretroviral treatment options in paediatric HIV infection.

Authors:  Carlo Giaquinto; Erika Morelli; Federica Fregonese; Osvalda Rampon; Martina Penazzato; Anita de Rossi; Ruggero D'Elia
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

2.  The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinics.

Authors:  Juan J Calva; Juan Sierra-Madero; Luis E Soto-Ramírez; Pedro Aguilar-Salinas
Journal:  Open Forum Infect Dis       Date:  2014-09-10       Impact factor: 3.835

3.  HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.

Authors:  Bin Lin; Xiaoguang Sun; Shengli Su; Cuixia Lv; Xiaofei Zhang; Lin Lin; Rui Wang; Jihua Fu; Dianmin Kang
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.